PMP22

Chr 17ADAR

peripheral myelin protein 22

Also known as: CIDP, CMT1A, CMT1E, DSS, GAS-3, GAS3, HMSNIA, HNPP

PMP22 encodes peripheral myelin protein 22, a component of the myelin Schwann cells wrap around peripheral nerves, and its disorders are mostly about dosage. A 1.4 Mb duplication of 17p12 that contains the gene (three copies) causes CMT1A, the commonest Charcot-Marie-Tooth disease: 43% of genetic diagnoses in a UK cohort of 1,165. The reciprocal deletion (one copy) causes hereditary neuropathy with liability to pressure palsies (HNPP). Both arise from recombination between repeats flanking the segment.

Across 4,291 genetically characterised patients, 75.6% had the duplication, 19.6% the deletion and 4.8% a sequence variant. Sequence variants cause CMT1E (onset in childhood or adolescence, more often with hearing or eye involvement), Dejerine–Sottas syndrome (early and severe) and a small share of HNPP (loss-of-function variants that copy the deletion).

CMT1A is a demyelinating neuropathy that usually presents with distal weakness and foot drop; HNPP with recurrent palsies at entrapment sites such as the peroneal and ulnar nerves. Test copy number first (MLPA): exome data can miss the duplication and deletion, and sequencing is for the copy-number-negative.

GeneReviewsOMIMResearchCurated summary · Cesaroni 2025, Record 2024, Sanders 2026

Primary Disease Associations & Inheritance

?Neuropathy, inflammatory demyelinatingMIM #139393
AD
Charcot-Marie-Tooth disease, type 1AMIM #118220
AD
Charcot-Marie-Tooth disease, type 1EMIM #118300
AD
Dejerine-Sottas diseaseMIM #145900
ADAR
Neuropathy, recurrent, with pressure palsiesMIM #162500
AD
Roussy-Levy syndromeMIM #180800
AD

Clinical highlights

Genetics
17p12 duplication (CMT1A) 75.6%, the reciprocal deletion (HNPP) 19.6%, sequence variants 4.8% of 4,291 genetically characterised patients.Cesaroni et al., Genes (Basel) 2025 (systematic review)
Testing order
Copy number first (MLPA), then sequencing if negative. Exome data can miss the duplication and the deletion.Record et al., Brain 2024
Sequence variants
CMT1E (often de novo) and Dejerine–Sottas syndrome (early and severe); loss-of-function variants can cause HNPP without a deletion (1.4% of HNPP).Cesaroni et al. 2025
Interpreting a novel variant
Most PMP22 disease is copy number, not sequence. A novel sequence variant is a CMT1E / Dejerine–Sottas or HNPP question, and only after the duplication and deletion are excluded.Curated for this gene — a prior for triage, not a per-variant call.
4
Active trials
108
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
—
LOEUF · n/a
Multiple*
Mechanism· predicted
📖
GeneReview available — PMP22
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

PMP22 disease is mostly copy number

Each bar is one chromosome 17; each box the 1.4 Mb segment of 17p12 that carries PMP22. Repeats flanking the segment let it be duplicated on one chromosome and lost from the other.

  • 2 copies → Normal

  • 3 copies → CMT1A

    75.6%

    Duplication of the segment. Demyelinating neuropathy, usually distal weakness and foot drop. Open in the CNV tool →

  • 1 copy → HNPP

    19.6%

    The reciprocal deletion. Recurrent palsies at entrapment sites (peroneal, ulnar). Open in the CNV tool →

  • 2 copies, one altered → CMT1E · Dejerine–Sottas · rarely HNPP

    4.8%

    A sequence variant in PMP22 itself.

Testing: copy number first (MLPA). Exome data can miss the duplication and the deletion, so a normal exome does not exclude them; sequence PMP22 when copy number is normal.

Percentages: share of 4,291 genetically characterised patients with PMP22 disease. Sources: Cesaroni et al., Genes (Basel) 2025 (systematic review); Record et al., Brain 2024; Sanders et al., Chem Rev 2026.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

PMP22 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.